Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 8, 1999 - Issue 6
Submit an article Journal homepage
83
Views
17
CrossRef citations to date
0
Altmetric
Drug Evaluation

Valspodar: current status and perspectives

Francis Loor Université de Strasbourg 1, Fédération de Recherches ‘Biotechnologie et Médicament’, Laboratoire d’Immunologie, BP 24, F-67401 Illkirch, France. [email protected]
Pages 807-835 | Published online: 23 Feb 2005

Citations (17)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Z. Binkhathlan, D. A. Hamdy, D. R. Brocks & A. Lavasanifar. (2010) Pharmacokinetics of PSC 833 (valspodar) in its Cremophor EL formulation in rat. Xenobiotica 40:1, pages 55-61.
Read now
Angiolo Gadducci, Stefania Cosio & Andrea Riccardo Genazzani. (2007) Novel targeted therapies in epithelial ovarian cancer: from basic research to the clinic. Expert Review of Endocrinology & Metabolism 2:2, pages 225-238.
Read now

Articles from other publishers (15)

Jun Kuwazuru, Mary Ann Suico, Kohei Omachi, Haruka Kojima, Misato Kamura, Shota Kaseda, Teppei Kawahara, Yuki Hitora, Hikaru Kato, Sachiko Tsukamoto, Mikiyo Wada, Toshifumi Asano, Shunsuke Kotani, Makoto Nakajima, Shogo Misumi, Yuya Sannomiya, Jun Horizono, Yuimi Koyama, Aimi Owaki, Tsuyoshi Shuto & Hirofumi Kai. (2023) CyclosporinA Derivative as Therapeutic Candidate for Alport Syndrome by Inducing Mutant Type IV Collagen Secretion. Kidney360 4:7, pages 909-917.
Crossref
Viktor Balzer, Pascal Poc, Elena Puris, Stefan Martin, Maryam Aliasgari, Seppo Auriola & Gert Fricker. (2022) Re-evaluation of the hCMEC/D3 based in vitro BBB model for ABC transporter studies. European Journal of Pharmaceutics and Biopharmaceutics 173, pages 12-21.
Crossref
Andrea J. Parsons, Tobias Cohen, Toni M. Schwarz, Kathryn R. Stein, Sabrina I. Ophir, Jailene Paredes Casado & Domenico Tortorella. (2021) Valspodar limits human cytomegalovirus infection and dissemination. Antiviral Research 193, pages 105124.
Crossref
Selva Jeganathan, Emily Budziszewski, Christopher Hernandez, Anshul Dhingra & Agata A. Exner. (2020) Improving Treatment Efficacy of In Situ Forming Implants via Concurrent Delivery of Chemotherapeutic and Chemosensitizer. Scientific Reports 10:1.
Crossref
Cong Luo, Jin Sun, Yuqian Du & Zhonggui He. (2014) Emerging integrated nanohybrid drug delivery systems to facilitate the intravenous-to-oral switch in cancer chemotherapy. Journal of Controlled Release 176, pages 94-103.
Crossref
Satyakam Singh, Nagarajan Rajendra Prasad, Khyati Kapoor, Eduardo E. Chufan, Bhargav A. Patel, Suresh V. Ambudkar & Tanaji T. Talele. (2014) Design, Synthesis, and Biological Evaluation of ( S )-Valine Thiazole-Derived Cyclic and Noncyclic Peptidomimetic Oligomers as Modulators of Human P-Glycoprotein (ABCB1) . ChemBioChem 15:1, pages 157-169.
Crossref
Ziyad Binkhathlan, Anooshirvan Shayeganpour, Dion R. Brocks & Afsaneh Lavasanifar. (2012) Encapsulation of P-glycoprotein inhibitors by polymeric micelles can reduce their pharmacokinetic interactions with doxorubicin. European Journal of Pharmaceutics and Biopharmaceutics 81:1, pages 142-148.
Crossref
Houchao Tao, Yue Weng, Rupeng Zhuo, Geoffrey Chang, Ina L. Urbatsch & Qinghai Zhang. (2011) Design and Synthesis of Selenazole-Containing Peptides for Cocrystallization with P-Glycoprotein. ChemBioChem 12:6, pages 868-873.
Crossref
Ziyad Binkhathlan, Dalia A. Hamdy, Dion R. Brocks & Afsaneh Lavasanifar. (2010) Development of a polymeric micellar formulation for valspodar and assessment of its pharmacokinetics in rat. European Journal of Pharmaceutics and Biopharmaceutics 75:2, pages 90-95.
Crossref
David E. Modrak, David V. Gold & David M. Goldenberg. (2006) Sphingolipid targets in cancer therapy. Molecular Cancer Therapeutics 5:2, pages 200-208.
Crossref
Julio C. Carrero, Haydee Lugo, D.Guillermo Pérez, César Ortiz-Martı́nez & Juan P. Laclette. (2004) Cyclosporin A inhibits calcineurin (phosphatase 2B) and P-glycoprotein activity in Entamoeba histolytica. International Journal for Parasitology 34:9, pages 1091-1097.
Crossref
Francis Loor, Françoise Tiberghien, Tom Wenandy, Agnès Didier & Rene Traber. (2002) Cyclosporins:  Structure−Activity Relationships for the Inhibition of the Human FPR1 Formylpeptide Receptor . Journal of Medicinal Chemistry 45:21, pages 4613-4628.
Crossref
Francis Loor, Françoise Tiberghien, Tom Wenandy, Agnès Didier & René Traber. (2002) Cyclosporins:  Structure−Activity Relationships for the Inhibition of the Human MDR1 P-Glycoprotein ABC Transporter . Journal of Medicinal Chemistry 45:21, pages 4598-4612.
Crossref
E. Teodori, S. Dei, S. Scapecchi & F. Gualtieri. (2002) The medicinal chemistry of multidrug resistance (MDR) reversing drugs. Il Farmaco 57:5, pages 385-415.
Crossref
H. Kürnsteiner, M. Zinner & U. Kück. 2002. Industrial Applications. Industrial Applications 129 155 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.